Difference between revisions of "Team:SYSU-MEDICINE"

Line 18: Line 18:
 
         /*font*/
 
         /*font*/
 
         *{
 
         *{
−
             font-family:"Helvetica-Neue-635ac8fbe16985","Arial",sans-serif;
+
             font-family:"HelveticaNeueW02-45Ligh","Helvetica Neue",Helvetica,Arial,sans-serif；
 
             letter-spacing: 0.1em;
 
             letter-spacing: 0.1em;
  
 
         }
 
         }
 
         #HQ_page h1,#HQ_page h2,#HQ_page h3,#HQ_page h4,#HQ_page h5,#HQ_page p{
 
         #HQ_page h1,#HQ_page h2,#HQ_page h3,#HQ_page h4,#HQ_page h5,#HQ_page p{
−
             font-family:"Helvetica-Neue-635ac8fbe16985","Arial",sans-serif;
+
             font-family:"HelveticaNeueW02-45Ligh","Helvetica Neue",Helvetica,Arial,sans-serif；
 
         }
 
         }
 
         #HQ_page p{
 
         #HQ_page p{

Revision as of 03:59, 13 October 2016

MSCavalry

-----MSCs of
next generation

Inflammatory diseases are an increasing cause of disability and even fatality. Currently, apart from common treatments, MSCs therapy is a promising candidate for curing inflammatory diseases. However, intravascular injected MSCs are criticized for its low homing efficiency and ambiguous distribution in human body.

This year, MSCavalry: MSCs of next generation is coming. SYSU-MEDICINE decide to engineer a set of MSCs (homo sapiens) with higher accuracy and we hope that our project can pave the way for future MSCs clinical application.